Director Dealing

RNS Number : 1074N
Oakley Capital Investments Limited
27 January 2021
 

27 January 2021

Oakley Capital Investments Limited

 

Director Dealing

 

Oakley Capital Investments Limited1 (the "Company"), was notified today of the following transaction by a Director of the Company:

David Till, an Alternate Director of the Company, has purchased 6750 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at a price of 292.00 pence per Ordinary Share. As a result, Mr. Till is now interested in 708,910 Ordinary Shares of the Company, representing 0.393 percent of the issued share capital.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

David Till

2

Reason for the notification

 

a)

Position/status

 

Alternate Director

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Oakley Capital Investments Limited

b)

LEI

 

213800KW6MZUK12CQ815

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of 1p each

 

 

 

 

BMG670131058

b)

Nature of the transaction

 

Acquisition

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

292.00 p

6,750

 

 

 

d)

Aggregated information

 

Aggregated volume

 

Price

 

N/A (single transaction)

e)

Date of the transaction

 

27 January 2021

f)

Place of the transaction

 

London Stock Exchange, Specialist Fund Segment

 

- ends -

 

For further information please contact:

 

Oakley Capital Limited

+44 20 7766 6900

Steven Tredget, Investor Relations

 

Greenbrook Communications Limited

+44 20 7952 2000

Alex Jones / Michael Russell / James Williams

 

Liberum Capital Limited (Financial Adviser & Broker)

+44 20 3100 2000

Gillian Martin / Owen Matthews

 

Notes:

LEI Number: 213800KW6MZUK12CQ815

About Oakley Capital Investments Limited ("OCI")

OCI is a Specialist Fund Segment ("SFS") traded investment vehicle, which provides access to the Oakley Funds2. It is a liquid vehicle that aims to provide capital growth and dividends to investors.

The Oakley Funds

Oakley Capital Private Equity L.P. and its successor funds, Oakley Capital Private Equity II, Oakley Capital Private Equity III, Oakley Capital IV and Oakley Capital Origin Fund are unlisted lower-mid to mid-market private equity funds with the aim of providing investors with significant long-term capital appreciation. The investment strategy of the funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement.

The Investment Adviser

Founded in 2002, Oakley Capital Limited has demonstrated the repeated ability to source attractive growth assets at attractive prices. To do this it relies on its sector and regional expertise, its ability to tackle transaction complexity and its deal generating entrepreneur network.

Important information

Specialist Fund Segment securities are not admitted to the Official List of the Financial Conduct Authority. Therefore the Company has not been required to satisfy the eligibility criteria for admission to listing on the Official List and is not required to comply with the Financial Conduct Authority's Listing Rules.

The Specialist Fund Segment is intended for institutional, professional, professionally advised and knowledgeable investors who understand, or who have been advised of, the potential risk from investing in companies admitted to the Specialist Fund Segment.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDDLFLFFLBBBZ
UK 100

Latest directors dealings